DNA Interstrand Cross-Linking Agents and their Chemotherapeutic Potential

被引:46
作者
Brulikova, L. [1 ]
Hlavac, J. [1 ]
Hradil, P. [1 ]
机构
[1] Palacky Univ, Fac Sci, Inst Mol & Translat Med, Dept Organ Chem, Olomouc 77146, Czech Republic
关键词
Chemotherapy; cytotoxicity; DNA; interstrand cross-link; ICL; repair; resistance; NUCLEOTIDE EXCISION-REPAIR; FANCONI-ANEMIA PATHWAY; GROUP DOMAIN PROTEINS; MINOR-GROOVE; ANTITUMOR-ACTIVITY; CANCER CELLS; IN-VITRO; ATAXIA-TELANGIECTASIA; REDUCTIVE ACTIVATION; SELECTIVE INHIBITOR;
D O I
10.2174/092986712803414295
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
DNA interstrand cross-linking (ICL) agents are an important group of cytotoxic drugs with the capability of binding covalently between two strands of DNA, thereby preventing vital processes such as replication or transcription in dividing cells. In anticancer therapy however, their potential is limited due to the resistance by various mechanisms. In order to develop highly effective antitumor drugs it is necessary to study both effective ICL formations and their subsequent repair mechanisms. This review presents an overview of development over the past decade and the use of both well-known and new DNA interstrand cross-linking agents. Their potential in applications especially as anticancer chemotherapeutics in the framework of current knowledge of repair mechanisms and development of combined chemotherapy is discussed.
引用
收藏
页码:364 / 385
页数:22
相关论文
共 136 条
  • [31] The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01
    Graves, PR
    Yu, LJ
    Schwarz, JK
    Gales, J
    Sausville, EA
    O'Connor, PM
    Piwnica-Worms, H
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (08) : 5600 - 5605
  • [32] Synthesis of the first examples of A-C8/C-C2 amide-linked pyrrolo[2,1-c][1,4]benzodiazepine dimers
    Gregson, SJ
    Howard, PW
    Thurston, DE
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (14) : 2277 - 2280
  • [33] Synthesis of a novel C2/C2′-exo unsaturated pyrrolobenzodiazepine cross-linking agent with remarkable DNA binding affinity and cytotoxicity
    Gregson, SJ
    Howard, PW
    Jenkins, TC
    Kelland, LR
    Thurston, DE
    [J]. CHEMICAL COMMUNICATIONS, 1999, (09) : 797 - 798
  • [34] Design, synthesis, and evaluation of a novel pyrrolobenzodiazepine DNA-interactive agent with highly efficient cross-linking ability and potent cytotoxicity
    Gregson, SJ
    Howard, PW
    Hartley, JA
    Brooks, NA
    Adams, LJ
    Jenkins, TC
    Kelland, LR
    Thurston, DE
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (05) : 737 - 748
  • [35] A mammalianized synthetic nitroreductase gene for high-level expression
    Grohmann, Maik
    Paulmann, Nils
    Fleischhauer, Sebastian
    Vowinckel, Jakob
    Priller, Josef
    Walther, Diego J.
    [J]. BMC CANCER, 2009, 9
  • [36] Using synthetic DNA interstrand crosslinks to elucidate repair pathways and identify new therapeutic targets for cancer chemotherapy
    Guainazzi, Angelo
    Schaerer, Orlando D.
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2010, 67 (21) : 3683 - 3697
  • [37] Psoralen interstrand cross-link repair is specifically altered by an adjacent triple-stranded structure
    Guillonneau, F
    Guieysse, AL
    Nocentini, S
    Giovannangeli, C
    Praseuth, D
    [J]. NUCLEIC ACIDS RESEARCH, 2004, 32 (03) : 1143 - 1153
  • [38] Hartley JA, 2000, ANGEW CHEM INT EDIT, V39, P3467
  • [39] SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity.: Part 1:: Cellular pharmacology, in vitro and initial in vivo antitumor activity
    Hartley, JA
    Spanswick, VJ
    Brooks, N
    Clingen, PH
    McHugh, PJ
    Hochhauser, D
    Pedley, RB
    Kelland, LR
    Alley, MC
    Schultz, R
    Hollingshead, MG
    Schweikart, KM
    Tomaszewski, JE
    Sausville, EA
    Gregson, SJ
    Howard, PW
    Thurston, DE
    [J]. CANCER RESEARCH, 2004, 64 (18) : 6693 - 6699
  • [40] Synthesis, cytotoxicity and DNA cross-linking activity of symmetrical dimers based upon the epoxide domain of the azinomycins
    Hartley, JA
    Hazrati, A
    Hodgkinson, TJ
    Kelland, LR
    Khanim, R
    Shipman, M
    Suzenet, F
    [J]. CHEMICAL COMMUNICATIONS, 2000, (23) : 2325 - 2326